1. Home
  2. SXT vs ADMA Comparison

SXT vs ADMA Comparison

Compare SXT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXT
  • ADMA
  • Stock Information
  • Founded
  • SXT 1882
  • ADMA 2004
  • Country
  • SXT United States
  • ADMA United States
  • Employees
  • SXT N/A
  • ADMA N/A
  • Industry
  • SXT Major Chemicals
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SXT Industrials
  • ADMA Health Care
  • Exchange
  • SXT Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • SXT 4.6B
  • ADMA 5.1B
  • IPO Year
  • SXT N/A
  • ADMA N/A
  • Fundamental
  • Price
  • SXT $113.48
  • ADMA $17.26
  • Analyst Decision
  • SXT Buy
  • ADMA Strong Buy
  • Analyst Count
  • SXT 2
  • ADMA 3
  • Target Price
  • SXT $110.00
  • ADMA $27.67
  • AVG Volume (30 Days)
  • SXT 531.8K
  • ADMA 3.3M
  • Earning Date
  • SXT 10-24-2025
  • ADMA 08-06-2025
  • Dividend Yield
  • SXT 1.46%
  • ADMA N/A
  • EPS Growth
  • SXT 53.07
  • ADMA 469.09
  • EPS
  • SXT 3.17
  • ADMA 0.85
  • Revenue
  • SXT $1,575,588,000.00
  • ADMA $474,174,000.00
  • Revenue This Year
  • SXT $4.48
  • ADMA $21.08
  • Revenue Next Year
  • SXT $5.78
  • ADMA $25.98
  • P/E Ratio
  • SXT $35.51
  • ADMA $20.42
  • Revenue Growth
  • SXT 4.95
  • ADMA 43.58
  • 52 Week Low
  • SXT $66.15
  • ADMA $13.50
  • 52 Week High
  • SXT $121.54
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • SXT 50.96
  • ADMA 46.87
  • Support Level
  • SXT $112.08
  • ADMA $16.87
  • Resistance Level
  • SXT $116.66
  • ADMA $17.58
  • Average True Range (ATR)
  • SXT 3.11
  • ADMA 0.56
  • MACD
  • SXT -0.69
  • ADMA 0.04
  • Stochastic Oscillator
  • SXT 14.98
  • ADMA 66.84

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: